Camurus proclaims constructive Part 3 outcomes from the ACROINNOVA 2 examine of octreotide SC depot (CAM2029) in acromegaly sufferers By Investing.com
Therapy nicely tolerated with a security profile in line with standard-of-care (SoC)Elevated…
By
Tycoon Herald
10 Min Read